Oral Novo Nordisk diabetes drug poses no more heart risk than placebo -study 06.11.2019 · Posted in Business News Article An experimental oral form of a Novo Nordisk drug for type 2 diabetes posed no greater risk of serious heart problems or death than a placebo in patients at high risk for such complications, according to data from a large study presented on Tuesday.